{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:13:19Z","timestamp":1788613999420,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000121","name":"National Science Foundation Division of Mathematical Sciences","doi-asserted-by":"publisher","award":["DMS-2451660"],"award-info":[{"award-number":["DMS-2451660"]}],"id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jtbi.2026.112574","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:45:16Z","timestamp":1786689916000},"page":"112574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Does human transthyretin aggregate in blood plasma or in cardiac tissue? A mathematical modeling study"],"prefix":"10.1016","volume":"634","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-6907","authenticated-orcid":false,"given":"Andrey V.","family":"Kuznetsov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2026.112574_b0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/10408363.2024.2350379","article-title":"Transthyretin mutagenesis: impact on amyloidogenesis and disease","volume":"61","author":"Almeida","year":"2024","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jtbi.2026.112574_b0010","article-title":"Tennis courts in the human body: a review of the misleading metaphor in medical literature","volume":"14","author":"Ananda Rao","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jtbi.2026.112574_b0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2502847122","article-title":"FibrilPaint to determine the length of Tau amyloids in fluids","volume":"122","author":"Aragon\u00e8s Pedrola","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112574_b0020","unstructured":"Beck, J.V., Arnold, K.J., 1977. Parameter Estimation in Science and Engineering. Wiley, New York."},{"key":"10.1016\/j.jtbi.2026.112574_b0025","unstructured":"Betts, J.G., 2013. Anatomy and Physiology, Open Textbook Library. OpenStax College, Rice University."},{"key":"10.1016\/j.jtbi.2026.112574_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.592644","article-title":"Modulation of the mechanisms driving transthyretin amyloidosis","volume":"13","author":"Bezerra","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jtbi.2026.112574_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03295","article-title":"Effect of nanoparticle concentration on coagulation rate of colloidal suspensions","volume":"6","author":"Boltachev","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jtbi.2026.112574_b0040","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cardfail.2016.10.008","article-title":"Transthyretin cardiac amyloidosis in older Americans","volume":"22","author":"Brunjes","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jtbi.2026.112574_b0275","doi-asserted-by":"crossref","first-page":"46181","DOI":"10.31083\/RCM46181","article-title":"Transthyretin cardiac amyloidosis and heart failure: state-of-the-art review and practice guidance","volume":"26","author":"Bukhari","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.jtbi.2026.112574_b0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.xphs.2018.01.013","article-title":"Measurement of average aggregate density by sedimentation and Brownian motion analysis","volume":"107","author":"Cavicchi","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"17","key":"10.1016\/j.jtbi.2026.112574_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13175140","article-title":"Epidemiological changes in transthyretin cardiac amyloidosis: evidence from In vivo data and autoptic series","volume":"13","author":"Cianci","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtbi.2026.112574_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-016-0040-x","article-title":"Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis","volume":"5","author":"Coelho","year":"2016","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jtbi.2026.112574_b0065","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s12035-024-04442-8","article-title":"Tetrameric transthyretin as a protective factor against Alzheimer\u2019s disease","volume":"62","author":"Corino","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jtbi.2026.112574_b0075","first-page":"22356","article-title":"Proposing a minimal set of metrics and methods to predict probabilities of amyloidosis disease and onset age in individuals","volume":"12","author":"Criddle","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jtbi.2026.112574_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304891","article-title":"Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils","volume":"19","author":"Criddle","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2026.112574_b0080","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17501911.2024.2373682","article-title":"Generations of epigenetic clocks and their links to socioeconomic status in the Health and Retirement Study","volume":"16","author":"Crimmins","year":"2024","journal-title":"Epigenomics"},{"key":"10.1016\/j.jtbi.2026.112574_b0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13023-023-02933-w","article-title":"Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases","volume":"18","author":"Damy","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jtbi.2026.112574_b0090","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1021\/acschemneuro.4c00127","article-title":"A\u03b2 oligomer dissociation is catalyzed by fibril surfaces","volume":"15","author":"Dear","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jtbi.2026.112574_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.20517\/2574-1209.2021.126","article-title":"Heart transplantation in cardiac amyloidosis","volume":"6","author":"Di Nora","year":"2022","journal-title":"Vessel Plus"},{"key":"10.1016\/j.jtbi.2026.112574_b0095","doi-asserted-by":"crossref","unstructured":"Dorbala, S., Cuddy, S., Falk, R., 2020. How to image cardiac amyloidosis: a practical approach. J. Am. Coll. Cardiol. Img. 13, 1368\u20131383. https:\/\/doi.org\/10.1016\/j.jcmg.2019.07.015.","DOI":"10.1016\/j.jcmg.2019.07.015"},{"key":"10.1016\/j.jtbi.2026.112574_b0100","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41556-024-01423-w","article-title":"Adding intrinsically disordered proteins to biological ageing clocks","volume":"26","author":"Dormann","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jtbi.2026.112574_b0105","doi-asserted-by":"crossref","first-page":"B79","DOI":"10.1093\/eurheartjsupp\/suad079","article-title":"Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis","volume":"25","author":"Emdin","year":"2023","journal-title":"European Heart Journal Supplements"},{"key":"10.1016\/j.jtbi.2026.112574_b0110","doi-asserted-by":"crossref","unstructured":"Esperante, S.A., Varej\u0101o, N., Pinheiro, F., Sant\u2019Anna, R., Luque-Ortega, J.R., Alfonso, C., Sora, V., Papaleo, E., Rivas, G., Reverter, D., Ventura, S., 2021. Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation. J. Biol. Chem. 297, 101039. https:\/\/doi.org\/10.1016\/j.jbc.2021.101039.","DOI":"10.1016\/j.jbc.2021.101039"},{"key":"10.1016\/j.jtbi.2026.112574_b0115","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1021\/acs.chemmater.0c00780","article-title":"Response to \u201cParticle size is a primary determinant for sigmoidal kinetics of nanoparticle formation: a \u2018disproof\u2019 of the Finke\u2013Watzky (F-W) nanoparticle nucleation and growth mechanism\"","volume":"32","author":"Finke","year":"2020","journal-title":"Chem. Mater."},{"issue":"7","key":"10.1016\/j.jtbi.2026.112574_b0120","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150131","article-title":"High-avidity binding drives nucleation of amyloidogenic transthyretin monomer","volume":"7","author":"Gao","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtbi.2026.112574_b0125","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s43587-021-00150-3","article-title":"Molecular damage in aging","volume":"1","author":"Gladyshev","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jtbi.2026.112574_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tem.2023.09.007","article-title":"The ticking of aging clocks","volume":"35","author":"Han","year":"2024","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.jtbi.2026.112574_b0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11897-022-00570-1","article-title":"Update on disease-specific biomarkers in transthyretin cardiac amyloidosis","volume":"19","author":"Hood","year":"2022","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.jtbi.2026.112574_b0140","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/acschemneuro.7b00251","article-title":"Finke-Watzky two-step nucleation-autocatalysis model of S100A9 amyloid formation: protein misfolding as \u201cnucleation\u201d event","volume":"8","author":"Iashchishyn","year":"2017","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.jtbi.2026.112574_b0145","doi-asserted-by":"crossref","unstructured":"Kittleson, M.M., Maurer, M.S., Ambardekar, A.V., Bullock-Palmer, R.P., Chang, P.P., Eisen, H.J., Nair, A.P., Nativi-Nicolau, J., Ruberg, F.L., On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, 2020. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation 142, e7\u2013e22. https:\/\/doi.org\/10.1161\/CIR.0000000000000792.","DOI":"10.1161\/CIR.0000000000000792"},{"key":"10.1016\/j.jtbi.2026.112574_b0150","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/ehf2.12986","article-title":"Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis","volume":"7","author":"Kocher","year":"2020","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.jtbi.2026.112574_b0155","doi-asserted-by":"crossref","unstructured":"Kuznetsov, A.V., 2026a. Predicting Biological Age Using an Accumulated Neurotoxicity Biomarker for Amyloid Beta Oligomers. Mathematical Medicine and Biology: A Journal of the IMA, dqag005. https:\/\/doi.org\/10.1093\/imammb\/dqag005.","DOI":"10.1093\/imammb\/dqag005"},{"key":"10.1016\/j.jtbi.2026.112574_b0160","doi-asserted-by":"crossref","unstructured":"Kuznetsov, A.V., 2026b. Modeling the growth of cytosolic TDP-43 inclusion bodies and accumulated neurotoxicity of misfolded oligomers in neurons. Comput. Methods Biomech. Biomed. Eng. 28, 1\u201328. https:\/\/doi.org\/10.1080\/10255842.2026.2618583.","DOI":"10.1080\/10255842.2026.2618583"},{"key":"10.1016\/j.jtbi.2026.112574_b0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10255842.2018.1534233","article-title":"Investigating sensitivity coefficients characterizing the response of a model of tau protein transport in an axon to model parameters","volume":"22","author":"Kuznetsov","year":"2019","journal-title":"Comput. Methods Biomech. Biomed. Eng."},{"key":"10.1016\/j.jtbi.2026.112574_b0170","doi-asserted-by":"crossref","unstructured":"Li, S.Z., Jain, A.K. (Eds.), 2009. Capillary blood vessel, Encyclopedia of Biometrics. Springer US, Boston, MA, p. 178. https:\/\/doi.org\/10.1007\/978-0-387-73003-5_133.","DOI":"10.1007\/978-0-387-73003-5_133"},{"key":"10.1016\/j.jtbi.2026.112574_b0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112574_b0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/echo.14245","article-title":"A histopathologic schema to quantify the burden of cardiac amyloidosis: Relationship with survival and echocardiographic parameters","volume":"36","author":"Mehta","year":"2019","journal-title":"Echocardiography"},{"key":"10.1016\/j.jtbi.2026.112574_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2024.1487260","article-title":"Critical review of aging clocks and factors that may influence the pace of aging","volume":"5","author":"Min","year":"2024","journal-title":"Front. Aging"},{"key":"10.1016\/j.jtbi.2026.112574_b0190","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via\u2009protein\u2009stabilization","volume":"93","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112574_b0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAF.0b013e31823d29ad","article-title":"Normal organ weights in men: part II-the brain, lungs, liver, spleen, and kidneys","volume":"33","author":"Molina","year":"2012","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.jtbi.2026.112574_b0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13506129.2022.2126308","article-title":"Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response","volume":"30","author":"Monteiro","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.jtbi.2026.112574_b0205","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s10741-022-10237-7","article-title":"Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis","volume":"27","author":"Morfino","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.jtbi.2026.112574_b0210","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1021\/bi701899y","article-title":"Fitting neurological protein aggregation kinetic data via a 2-step, Minimal\/\u201cOckham\u2019s Razor\u201d model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth","volume":"47","author":"Morris","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtbi.2026.112574_b0215","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.004802","article-title":"Serum transthyretin: predictor of amyloidosis outcomes?","volume":"11","author":"Nativi-Nicolau","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.jtbi.2026.112574_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/13506129.2020.1808783","article-title":"Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma","volume":"28","author":"Nelson","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.jtbi.2026.112574_b0225","series-title":"Neurotherapeutics in the Era of Translational Medicine","first-page":"65","article-title":"Chapter 4 - from uncovering the mechanism of transthyretin aggregation to the drug tafamidis for ameliorating neurodegeneration and cardiomyopathy","author":"Powers","year":"2021"},{"key":"10.1016\/j.jtbi.2026.112574_b0230","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","article-title":"The tetrameric protein transthyretin dissociates to a non-native monomer in solution - a novel model for amyloidogenesis","volume":"274","author":"Quintas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtbi.2026.112574_b0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-023-00651-2","article-title":"Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases","volume":"19","author":"Rinauro","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jtbi.2026.112574_b0240","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtbi.2026.112574_b0245","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jtbi.2026.112574_b0250","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/biomedicines10081906","article-title":"The journey of human transthyretin: synthesis, structure stability, and catabolism","volume":"10","author":"Sanguinetti","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtbi.2026.112574_b0255","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtbi.2026.112574_b0260","unstructured":"Sharma, R., Sharma, S., 2025. Physiology, Blood Volume., in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.jtbi.2026.112574_b0265","first-page":"541","article-title":"Transthyretin cardiac amyloidosis: an evolution in diagnosis and management of an \u201cold\u201d disease","volume":"40","author":"Smiley","year":"2022","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.jtbi.2026.112574_b0270","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1038\/s41467-023-43301-3","article-title":"Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis","volume":"14","author":"Steinebrei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtbi.2026.112574_b0280","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.febslet.2015.07.006","article-title":"The route to protein aggregate superstructures: particulates and amyloid-like spherulites","volume":"589","author":"Vetri","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jtbi.2026.112574_b0285","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10522-022-09997-4","article-title":"An evaluation of aging measures: from biomarkers to clocks","volume":"24","author":"Wang","year":"2023","journal-title":"Biogerontology"},{"key":"10.1016\/j.jtbi.2026.112574_b0290","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1021\/ja8017412","article-title":"Transition-metal nanocluster size vs formation time and the catalytically effective nucleus number: a mechanism-based treatment","volume":"130","author":"Watzky","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jtbi.2026.112574_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.1015545","article-title":"Current and potential therapeutic strategies for transthyretin cardiac amyloidosis","volume":"2","author":"Williams","year":"2022","journal-title":"Front. Drug Discovery"},{"key":"10.1016\/j.jtbi.2026.112574_b0300","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41467-024-50692-4","article-title":"\u03b1-Synuclein oligomers form by secondary nucleation","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtbi.2026.112574_b0305","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jtbi.2010.03.028","article-title":"A class of exact solutions for biomacromolecule diffusion-reaction in live cells","volume":"264","author":"Zadeh","year":"2010","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2026.112574_b0310","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1049\/iet-syb.2011.0015","article-title":"Sensitivity analysis approaches applied to systems biology models","volume":"5","author":"Zi","year":"2011","journal-title":"IET Syst. Biol."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326001992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326001992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:44:07Z","timestamp":1788612247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519326001992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":62,"alternative-id":["S0022519326001992"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112574","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does human transthyretin aggregate in blood plasma or in cardiac tissue? A mathematical modeling study","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112574"}}